NCT02522182Completed
ALLiance for sEcondary PREvention After an Episode of Acute Coronary Syndrome (ALLEPRE)
ALLiance for sEcondary PREvention After an Episode of Acute Coronary Syndrome. The ALLEPRE Trial: a Fully Nurse-led Intensive Intervention Programme
Source: ClinicalTrials.gov · Last updated 26 Mar 2025
Brief summary (registry, in English)
The purpose of the ALLEPRE trial is to compare the benefit offered by a structured, intensive and fully nurse-led intensive secondary prevention intervention programme with that offered by standard of care in a high-risk population of patients admitted to hospital because of an ACS.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 2060 (actual)
- First submitted
- 21 Jul 2015
- Start date
- 1 Oct 2012
- Primary completion date
- 31 Jan 2025
- Lead sponsor
- Azienda Ospedaliero-Universitaria di Parma
- Diseases
- Coronary artery disease
- NCT number
- NCT02522182
What you commit to
- Study type: Interventional
- Participants enrolled: 2060
- From 1 Oct 2012 to the primary completion date, 31 Jan 2025
- 7 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Once it has been verified that the patients are capable of participating in a prospective study, the only exclusion criterion is a life expectancy of b12 months because of a severe noncardiac disease
Who the study is looking for
- Eligible patients aged \>18 years with an ACS (unstable angina, non- ST-segment elevation myocardial infarction \[MI\], or ST-segment elevation MI \[International Classification of Diseases, Ninth Revision, Clinical Modification codes 41071, 41001, 41011, 41021, 41031, 41041, 41051,41061, 41081, and 41091\]) who are admitted to the Cardiological Divisions of the 6 participating centers in Emilia-Romagna (Italy) are considered for enrolment for up to 20 days after the index event and before being discharged.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (7)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ospedale di Baggiovara Coordinator of this site? Confirm its status | Baggiovara | Italy | Unknown status |
| Ospedale Ramazzini di Carpi Coordinator of this site? Confirm its status | Carpi | Italy | Unknown status |
| Ospedale Sant'Anna Coordinator of this site? Confirm its status | Castelnovo ne' Monti | Italy | Unknown status |
| Ospedale di Vaio Coordinator of this site? Confirm its status | Fidenza | Italy | Unknown status |
| Ospedale Civile di Guastalla Coordinator of this site? Confirm its status | Guastalla | Italy | Unknown status |
| Azienda Ospedaliero Universitaria di Parma Coordinator of this site? Confirm its status | Parma | Italy | Unknown status |
| Ospedale Guglielmo da Saliceto Coordinator of this site? Confirm its status | Piacenza | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.